Lipopolysaccharide-binding protein and future Parkinson’s disease risk: a European prospective cohort

Abstract Introduction Lipopolysaccharide (LPS) is the outer membrane component of Gram-negative bacteria. LPS-binding protein (LBP) is an acute-phase reactant that mediates immune responses triggered by LPS and has been used as a blood marker for LPS. LBP has recently been indicated to be associated...

詳細記述

書誌詳細

主要な著者:	Yujia Zhao, Douglas I. Walker, Christina M. Lill, Bastiaan R. Bloem, Sirwan K. L. Darweesh, Brismar Pinto-Pacheco, Brooklyn McNeil, Gary W. Miller, Alicia K. Heath, Myrthe Frissen, Dafina Petrova, Maria-Jose Sánchez, María-Dolores Chirlaque, Marcela Guevara, Maurizio Zibetti, Salvatore Panico, Lefkos Middleton, Verena Katzke, Rudolf Kaaks, Elio Riboli, Giovanna Masala, Sabina Sieri, Raul Zamora-Ros, Pilar Amiano, Mazda Jenab, Susan Peters, Roel Vermeulen
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2023-07-01
シリーズ:	Journal of Neuroinflammation
主題:	Parkinson’s disease Lipopolysaccharide-binding protein Pre-diagnostic Systemic inflammation Endotoxemia
オンライン･アクセス:	https://doi.org/10.1186/s12974-023-02846-2
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!